X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12821) 12821
Book Review (2704) 2704
Publication (1057) 1057
Newsletter (235) 235
Book Chapter (93) 93
Conference Proceeding (78) 78
Newspaper Article (26) 26
Book / eBook (23) 23
Magazine Article (13) 13
Dissertation (10) 10
Transcript (6) 6
Reference (2) 2
Trade Publication Article (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11156) 11156
humans (9089) 9089
autoantibodies (6315) 6315
female (5958) 5958
male (4794) 4794
animals (4316) 4316
autoantibodies - blood (3233) 3233
autoimmunity (3172) 3172
adult (3138) 3138
middle aged (2995) 2995
immunology (2936) 2936
mice (2708) 2708
autoantibodies - immunology (2488) 2488
antibodies (2164) 2164
aged (1862) 1862
abridged index medicus (1678) 1678
disease (1333) 1333
adolescent (1222) 1222
autoantibodies - analysis (1165) 1165
rheumatology (1089) 1089
research (1043) 1043
autoimmune diseases (1036) 1036
treatment outcome (1000) 1000
child (971) 971
disease models, animal (949) 949
immunoglobulins (949) 949
analysis (946) 946
autoimmune diseases - immunology (928) 928
systemic lupus erythematosus (908) 908
lupus (898) 898
care and treatment (892) 892
endocrinology & metabolism (862) 862
rats (836) 836
diagnosis (825) 825
enzyme-linked immunosorbent assay (811) 811
health aspects (807) 807
risk factors (789) 789
autoantibodies - biosynthesis (784) 784
hematology (780) 780
therapy (755) 755
medicine & public health (751) 751
lupus erythematosus, systemic - immunology (747) 747
autoantigens - immunology (742) 742
neurosciences (742) 742
inflammation (733) 733
antigens (723) 723
immunoglobulin g (689) 689
proteins (689) 689
systemic-lupus-erythematosus (677) 677
clinical neurology (653) 653
mice, inbred c57bl (636) 636
expression (625) 625
pregnancy (605) 605
pathogenesis (603) 603
medicine, general & internal (599) 599
young adult (583) 583
rheumatoid-arthritis (581) 581
autoantibody (579) 579
time factors (576) 576
b-lymphocytes - immunology (574) 574
patients (573) 573
immunosuppressive agents - therapeutic use (569) 569
mice, inbred balb c (549) 549
article (546) 546
immunotherapy (541) 541
physiological aspects (536) 536
t-cells (532) 532
t-lymphocytes - immunology (530) 530
medical research (528) 528
dermatology (525) 525
medicine (521) 521
child, preschool (508) 508
cytokines (504) 504
immunization (502) 502
internal medicine (502) 502
follow-up studies (500) 500
t cells (499) 499
diabetes mellitus, type 1 - immunology (494) 494
children (488) 488
aged, 80 and over (485) 485
retrospective studies (485) 485
viral antibodies (484) 484
rituximab (478) 478
cells (476) 476
rheumatoid arthritis (476) 476
research article (475) 475
diabetes (474) 474
immunoglobulin g - immunology (470) 470
lymphocytes (466) 466
development and progression (460) 460
prognosis (458) 458
multidisciplinary sciences (444) 444
allergy and immunology (443) 443
biomarkers - blood (436) 436
immunoglobulin g - blood (432) 432
arthritis (428) 428
medicine, research & experimental (425) 425
dosage and administration (391) 391
prevalence (391) 391
pediatrics (388) 388
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12427) 12427
Japanese (267) 267
German (140) 140
French (108) 108
Russian (94) 94
Spanish (34) 34
Polish (26) 26
Chinese (19) 19
Italian (19) 19
Hungarian (16) 16
Dutch (7) 7
Czech (5) 5
Korean (5) 5
Portuguese (4) 4
Bulgarian (2) 2
Croatian (2) 2
Danish (2) 2
Serbian (2) 2
Swedish (2) 2
Turkish (2) 2
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Science Translational Medicine, ISSN 1946-6234, 04/2014, Volume 6, Issue 230, pp. 230ra45 - 230ra45
Journal Article
Muscle & Nerve, ISSN 0148-639X, 12/2018, Volume 58, Issue 6, pp. 801 - 804
Journal Article
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 01/2019, Volume 58, Issue 1, pp. 114 - 125
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2017, Volume 76, Issue 11, pp. 1837 - 1844
ObjectivesSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease associated with diffuse immune cell dysfunction. CD40–CD40 ligand (CD40L)... 
pharmacokinetics | systemic lupus erythematosus | autoantibodies | autoimmune disease | BILAG 2004 | UPDATED VERSION | CD40 LIGAND | MONOCLONAL-ANTIBODY | COSTIMULATION | COMPLICATIONS | RHEUMATOLOGY | ACTIVITY INDEX | Severity of Illness Index | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Immunologic Factors - administration & dosage | Male | Treatment Outcome | Lupus Erythematosus, Systemic - blood | Transcriptome - drug effects | Polyethylene Glycols - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Administration, Intravenous | Immunoglobulin Fab Fragments - administration & dosage | CD40 Ligand - drug effects | Adolescent | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Aged | RNA - blood | Treatment outcome | Usage | Care and treatment | Systemic lupus erythematosus | Polyethylene glycol | Analysis | Intravenous administration | CD40 antigen | Disease | Clinical trials | Antibodies | Arthritis | CD40L protein | Blood platelets | Lymphocytes | Rodents | Thromboembolism | Antinuclear antibodies | Deoxyribonucleic acid--DNA | Immune system | Lupus | Antigens | Polyethylene | Immunoglobulins | Immunomodulation | Fab | Rheumatology | Antiphospholipid antibodies | Gene expression | Ribonucleic acid--RNA | Studies | Lymphocytes B | Antigen-presenting cells | Ligands | Autoimmune diseases | Index Medicus
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 06/2018, Volume 32, Issue 6, pp. 1004 - 1010
BackgroundIntravenous immunoglobulins (IVIG) are an attractive therapeutic tool for therapy of toxic epidermal necrolysis and severe forms of certain... 
ANTIBODIES | AUTOANTIBODIES | GLOBULIN | IMMUNE THROMBOCYTOPENIC PURPURA | NEUTROPENIA | COMPLICATION | HEMOLYSIS | NEUTROPHILS | MECHANISMS | IVIG THERAPY | DERMATOLOGY | Lupus | Medical research | Immunoglobulins | Biological products | Anemia | Medicine, Experimental | Skin diseases | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2010, Volume 107, Issue 29, pp. 13075 - 13080
Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases.... 
T lymphocytes | Animal models | Disease models | Gels | B lymphocytes | B cell lymphoma | Arthritis | Mice | Autoimmune diseases | Tumors | X-linked agammaglobulinemia | Lymphoma | COLLAGEN-INDUCED ARTHRITIS | THERAPY | RITUXIMAB | MULTIDISCIPLINARY SCIENCES | lymphoma | DOGS | FAMILY KINASES | BTK | RECEPTOR | DEPLETION | MICE | Arthritis, Experimental - drug therapy | Pyrazoles - therapeutic use | Humans | Benzofurans - administration & dosage | Benzofurans - pharmacology | Autoantibodies - biosynthesis | Pyrimidines - chemistry | Benzofurans - chemistry | Protein Kinase Inhibitors - chemistry | Pyrazoles - chemistry | Lymphoma, B-Cell - enzymology | Autoimmune Diseases - drug therapy | Disease Models, Animal | Lymphoma, B-Cell - drug therapy | Pyrazoles - pharmacology | B-Lymphocytes - enzymology | Benzofurans - therapeutic use | Autoimmune Diseases - enzymology | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Pyrimidines - pharmacology | Receptors, Antigen, B-Cell - immunology | B-Lymphocytes - drug effects | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Animals | B-Lymphocytes - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Dogs | Protein Kinase Inhibitors - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Cell receptors | Models | Lymphomas | Research | Properties | Antigens | Biochemistry | Mutation | Kinases | Cells | Cancer | Index Medicus | Biological Sciences
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 15, pp. 1179 - 1185
Journal Article
Diabetes care, ISSN 0149-5992, 11/2018, Volume 41, Issue 11, pp. 2353 - 2360
OBJECTIVEType B insulin resistance due to autoantibodies against the insulin receptor is characterized by diabetes refractory to massive doses of insulin,... 
AUTOANTIBODIES | ANTIBODIES | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HODGKINS-DISEASE | CYCLOPHOSPHAMIDE | RITUXIMAB | ENDOCRINOLOGY & METABOLISM | CHRONIC LYMPHOCYTIC-LEUKEMIA | RECEPTOR | AUTOIMMUNE HYPOGLYCEMIA | CLINICAL-COURSE | Antigens, CD - immunology | Azathioprine - therapeutic use | Cyclophosphamide - administration & dosage | Follow-Up Studies | Autoantibodies - blood | Humans | Middle Aged | Diabetes Mellitus, Type 1 - metabolism | Dexamethasone - adverse effects | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Hyperglycemia - drug therapy | Adult | Female | Remission Induction - methods | Maintenance Chemotherapy | Diabetes Mellitus, Type 1 - immunology | Drug Therapy, Combination | Receptor, Insulin - immunology | Immunosuppressive Agents - administration & dosage | Rituximab - adverse effects | Severity of Illness Index | Dexamethasone - administration & dosage | Hyperglycemia - immunology | Insulin - administration & dosage | Syndrome | Diabetes Mellitus, Type 1 - drug therapy | Rituximab - administration & dosage | Hyperglycemia - blood | Immunosuppressive Agents - adverse effects | Insulin Resistance - immunology | Insulin - adverse effects | Cohort Studies | Methylprednisolone - administration & dosage | Insulin resistance | Dosage and administration | Research | Diabetes | Drug therapy | Immunosuppressive agents | Therapy | Fasting | Autoantibodies | Mortality | Diabetes mellitus | Rituximab | Disease management | Glucose | Insulin | Patients | Testosterone | Cohort analysis | Cyclophosphamide | Hyperglycemia | Immunotherapy | Remission | Research design | Azathioprine | Steroid hormones | Steroids | Index Medicus
Journal Article